Asma Hussaini, PA
Physician Assistant · Thousand Oaks, CANPI 1588893838
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 82.4% of it on its own, with 28 other manufacturers making up the rest. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 359 payments — averaging $283.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$84K
- Medtronic$8K
- Boston Scientific$6K
- Shockwave Medical, Inc$358
- Edwards Lifesciences$344
- Amgen$330
- plus $2K from 23 others
What the payments were for
- Consulting fees$30,63830%
- Speaking & faculty fees$38,07937%
- Travel & lodging$19,76519%
- Food & beverage$13,45313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 196 | $83,955 |
| Medtronic | 68 | $8,456 |
| Boston Scientific | 25 | $6,316 |
| Shockwave Medical, Inc | 3 | $358 |
| Edwards Lifesciences | 3 | $344 |
| Amgen | 10 | $330 |
| W. L. Gore & Associates, Inc. | 3 | $275 |
| Pfizer | 8 | $211 |
| Alnylam Pharmaceuticals Inc. | 5 | $193 |
| Abiomed | 2 | $186 |
| AstraZeneca | 6 | $175 |
| Altathera Pharmaceuticals LLC | 1 | $159 |
| Irhythm Technologies, Inc. | 5 | $151 |
| Heartflow, Inc. | 3 | $144 |
| Inari Medical, Inc. | 1 | $112 |
| Penumbra, Inc. | 1 | $106 |
| Novartis | 4 | $96 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $45 |
| Johnson & Johnson | 1 | $39 |
| United Therapeutics Corporation | 1 | $33 |
| Cordis US CORP. | 1 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Atricure, Inc. | 1 | $26 |
| Novo Nordisk | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Lemaitre Vascular, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$42,228
- NAVITOR$20,623
- MitraClip System$16,440
- COREVALVE EVOLUT R$7,426
- WATCHMAN Access System$4,809
- PORTICO$334
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$292
- WATCHMAN FLX$279
- AMPLATZER$277
- EVOQUE$217
- DRAGONFLY OPSTAR$178
- Sotalol Hydrochloride$159
- GORE CARDIOFORM Septal Occluder$154
- Impella$140
- Repatha$121
- AMPLATZER AMULET$120
- Farapulse$116
- Watchman$113
- FLOWTRIEVER CATHETER, S$112
- CT THROMBECTOMY SYSTEM KIT$112
How this compares
$101,935 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $74,975 |
| EntrestoSacubitril/Valsartan | 40 | $34,736 |
| FarxigaDapagliflozin Propanediol | 45 | $29,804 |
| MultaqDronedarone Hcl | 22 | $11,775 |
| Metoprolol Succinate | 104 | $1,157 |
| ClopidogrelClopidogrel Bisulfate | 61 | $778 |
| Bumetanide | 20 | $592 |
| Potassium Chloride | 43 | $576 |
| Carvedilol | 94 | $475 |
| Atorvastatin Calcium | 76 | $435 |
| Valsartan | 13 | $412 |
| Furosemide | 104 | $386 |
| Amlodipine Besylate | 54 | $350 |
| Torsemide | 16 | $202 |
| Losartan Potassium | 18 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $211 | $74,975123 claims |
| NovartisEntresto | $96 | $34,73640 claims |
| AstraZenecaFarxiga | $175 | $29,80445 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Thousand Oaks
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
- Michael FloresLynwood$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.